The role of thrombolytic therapy in pulmonary embolism
Open Access
- 2 April 2015
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 125 (14) , 2191-2199
Abstract
M.T. is a 37-year-old whitemale with no significant past medical history who presented with sudden onset of tachypnea and chest pain, and was found to have hypoKeywords
This publication has 44 references indexed in Scilit:
- Six-Month Echocardiographic Study in Patients With Submassive Pulmonary Embolism and Right Ventricle Dysfunction: Comparison of Thrombolysis With HeparinThe American Journal of the Medical Sciences, 2011
- Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trialRespiratory Research, 2009
- Estimated case fatality rate of pulmonary embolism, 1979 to 1998The American Journal of Cardiology, 2004
- Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusionThe Lancet, 1993
- PAIMS 2: Alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2JACC, 1992
- Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trialJACC, 1992
- Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: A European multicenter double-blind trialJACC, 1992
- RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISMThe Lancet, 1988
- A Controlled Clinical Trial of Streptokinase and Heparin in the Treatment of Major Pulmonary EmbolismActa Medica Scandinavica, 1978
- Comparison by Controlled Clinical Trial of Streptokinase and Heparin in Treatment of Life-threatening Pulmonary EmbolismBMJ, 1974